The most common cause of death from anti‐CTLA‐4 was colitis (70%), whereas pneumonia (35%), hepatitis (22%), and neurological toxicities (15%) were the main causes of death from anti‐PD‐1/PD‐L1. This evidence concerns the gene CTLA4 and colitis.